Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-031500

Director acquired 200,002 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lamond David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-19 Grant or award : show line 1 in the form +200,002 1,734,722 I
Loading xslF345X03/doc4.xml…